AG0027HY

183321-74-6 | 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-

Chemical structure of 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, CAS 183321-74-6
AG0027HY
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 183321-74-6
Catalog Number AG0027HY(AGN-PC-04S31Q)
Chemical Name 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
IUPAC Name N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
InChI InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)
InChI Key AAKJLRGGTJKAMG-UHFFFAOYSA-N
MDL Number MFCD02089651
Molecular Formula C22H23N3O4
Molecular Weight 393.4357
SMILES C(#C)C=1C=C(C=CC1)NC1=NC=NC2=CC(=C(C=C12)OCCOC)OCCOC
UNII J4T82NDH7E
Synonyms
11C erlotinib, 11C-erlotinib, 358,774, CP, 358774, CP, CP 358,774, CP 358774, CP-358,774, CP-358774, CP358,774, CP358774, erlotinib, erlotinib HCl, erlotinib hydrochloride, HCl, Erlotinib, Hydrochloride, Erlotinib, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine, OSI 774, OSI-774, OSI774, Tarceva, Erlotinib, 183321-74-6, N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine, OSI-774, 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline, UNII-J4T82NDH7E, 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, NSC 718781, CHEMBL553, J4T82NDH7E, [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE, CP358774, CHEBI:114785, N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, NCGC00164574-01, AK142763, DSSTox_CID_26454, DSSTox_RID_81628, DSSTox_GSID_46454, Erlotinib(Tarceva), CAS-183321-74-6, NSC718781, Erlotinib, OS-774, RG-1415, Erlotinib [INN:BAN], SR-05000001460, erlotinibum, Erotinib, R-1415, erlotinib;, HSDB 8082, OSI 744, Erlotinib free base, nchembio866-comp3, Kinome_3317, n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride, R 1415, AC1L42EI, SCHEMBL8413, BDBM5446, BIFK0019, cid_176870, GTPL4920, QUI124, DTXSID8046454, OSI-744, QCR-100, AAKJLRGGTJKAMG-UHFFFAOYSA-N, ZX-AFC000128, HMS2089F05, HMS3244M19, HMS3244M20, HMS3244N19, HMS3713C22, AMX10161, ZINC1546066, Tox21_112202, 3615AH, AC-399, FC0029, MFCD02089651, s7786, STK623143, [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine, AKOS000282911, Tox21_112202_1, API0024668, CCG-220420, CS-0620, DB00530, MCULE-7764565391, RL02337, Ro-508231, SB16916, NCGC00164574-03, NCGC00164574-05, NCGC00164574-06, NCGC00164574-14, AJ-26877, AN-15876, AS-35132, BC215797, BCB03_000783, CJ-05292, EN002711, HY-50896, P443, SY028059, AB0017012, AB1004620, LS-184395, AM20090621, FT-0083688, FT-0651539, ST24046689, KS-00000642, MFCD02089651 (95%), A11416, K00241, S-7717, 15214-EP2269994A1, 15214-EP2272827A1, 15214-EP2281815A1, 15214-EP2292234A1, 15214-EP2292615A1, 15214-EP2295432A1, 15214-EP2298778A1, 15214-EP2301533A1, 15214-EP2301933A1, 15214-EP2305640A2, 15214-EP2305671A1, 15214-EP2305687A1, 15214-EP2308855A1, 15214-EP2311827A1, 15214-EP2311840A1, 15214-EP2311842A2, 15214-EP2316832A1, 15214-EP2316833A1, 32334-EP2281815A1, 32334-EP2292615A1, 32334-EP2301933A1, 32334-EP2305640A2, 32334-EP2305671A1, 32334-EP2311827A1, AB01273955-01, AB01273955-02, AB01273955-03, 134172-EP2292233A2, 321E746, I01-1241, SR-05000001460-1, SR-05000001460-2, SR-05000001460-3, SR-05000001460-6, BRD-K70401845-003-04-7, n-(3-ethynylphenyl)(6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amine, n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy) quinazolin-4-amine, 4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-Quinazolinamine; Erlotinin; Erlotinib Base, Tarceva, Erlotinib Base, erlotinib HCl, Erlotinib hydrochloride, Erlotinin, Erlotinib [INN], 11C-erlotinib, Tarceva (TN), D07POC, Erlotinib, 98% - 1G 1g, Tyrosine Kinase Inhibitor - Ns, CP-358774, C22H23N3O4, 183321-74-6 (free base), CID176870, C22-H23-N3-O4, ACN-036244, CS-O-31362, CP 358,774, CP-358,774, CP 358774, 2159B, A3397, CP-358,774-01, C400278, 183319-69-9, AQ4, n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine, Erlortinib; 4-[(3-Ethynylphenyl)Amino]-6,7-Bis(2-Methoxyethoxy)Quinazoline, 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1),

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited